Correction: Immune-Related Adverse Events Associated with Checkpoint-Inhibition Therapy

In the summary Immune-Related Adverse Events Associated with Checkpoint-Inhibition Therapy, we incorrectly suggested that treatment for immune-related adverse events from checkpoint inhibitor therapy is largely supportive. In fact, therapy with glucocorticoids is necessary for most such adverse events. The incorrect sentence has been removed.

We apologize for the error.